Personalized medicine for breast cancer: it is a new day!

被引：4

作者：

Russell, Christy A. ^{[1
]}

机构：

[1] Univ So Calif, Dept Med, Los Angeles, CA 90033 USA

来源：

AMERICAN JOURNAL OF SURGERY | 2014年 / 207卷 / 03期

关键词：

Breast cancer; Personalized medicine; Estrogen receptor; HER2 positive breast cancer; Triple negative breast cancer; TRASTUZUMAB; ONCOGENE; SUBTYPES; THERAPY;

D O I：

10.1016/j.amjsurg.2013.10.016

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Breast cancer remains the most common cancer diagnosed in women in the United States and is second only to lung cancer as a cause of cancer mortality. Breast cancer has become the prototypical solid tumor where targets have been identified within the tumor allowing for a personalized approach of systemic therapy. (C) 2014 Elsevier Inc. All rights reserved.

引用

页码：321 / 325

页数：5